Medisat Pharmaceuticals Porur, Chennai, Tamil Nadu

The combination of casirivimab and imdevimab is an investigational drug product being studied in the US and Canada to treat coronavirus disease, also known as COVID-19. In the US, this product is not FDA-approved; however, it is FDA-authorized for emergency use to treat COVID-19. Casirivimab/imdevimab, sold under the brand name REGEN-COV among others, is a medicine developed by the American biotechnology company Regeneron Pharmaceuticals. It is an artificial "antibody cocktail" designed to produce resistance against the SARS-CoV-2 coronavirus responsible for the COVID-19 pandemic

Color : white

Packaging Type : Glass vial

With the help of our sourcing parter we can help our customer to offer wide range of Tocilizumab Medication which are usefull in treatment of covid 19 at good price Actemra Tocilizumab is used for the treatment of ankylosing spondylitcs, arthritis, Psoriasis ulcreative Colitis & Crohn's disease. It is also use for the treatment of COVID 19 patients who have persistent reduction in their Oxygen level which continues to get worse.  

Country of Origin : India